Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oeso-phageal junction cancer (ToGA) : a phase 3' open-label, randomised controlled trial
収録刊行物
-
- Lancet
-
Lancet 376 687-697, 2010